Recent Posts
- ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
- New European-African Project that will develop UNIVERSAL treatments for children living with HIV
- EU grants Marketing Authorisation to first-ever dispersible-tablet dolutegravir
- Cheaper HIV treatment for children: a report in the Lancet
- European Medicines Agency approves use of Dolutegravir 5 mg dispersible tablet for younger children living with HIV
Recent Comments